Nicholas S Buckley
Overview
Explore the profile of Nicholas S Buckley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salpeter S, Buckley J, Buckley N, Bruera E
J Palliat Med
. 2014 Dec;
18(2):114-9.
PMID: 25494475
Objective: Our aim was to evaluate the use of very-low-dose methadone with haloperidol in the acute-care setting. Methods: We reviewed the records of 735 hospitalized patients receiving a palliative care...
2.
Lin A, Buckley N, Lu A, Kouzminova N, Salpeter S
Clin Colorectal Cancer
. 2011 May;
10(1):63-9.
PMID: 21609938
Background: Emerging data suggest that somatic KRAS mutation in advanced colorectal cancer is a strong predictor of non-response to anti-epidermal growth factor receptor antibody (anti-EGFR) therapy. Patients And Methods: A...
3.
Salpeter S, Wall A, Buckley N
Am J Med
. 2010 Feb;
123(4):322-8.e2.
PMID: 20176343
Background: It is unclear whether long-acting beta-agonists with concomitant inhaled corticosteroids increase asthma-related intubations and deaths. We pooled data on long-acting beta-agonists with variable and concomitant inhaled corticosteroids to evaluate...
4.
Salpeter S, Cheng J, Thabane L, Buckley N, Salpeter E
Am J Med
. 2009 Oct;
122(11):1016-1022.e1.
PMID: 19854329
Background: There is uncertainty over the risks and benefits of hormone therapy. We performed a Bayesian meta-analysis to evaluate the effect of hormone therapy on total mortality in younger postmenopausal...
5.
Lu A, Salpeter S, Reeve A, Eschrich S, Johnston P, Barrier A, et al.
Clin Colorectal Cancer
. 2009 Oct;
8(4):207-14.
PMID: 19822511
Purpose: The use of adjuvant therapy in stage II colorectal cancer (CRC) remains controversial. There is a need to identify more effective predictors than the traditional staging system to aid...
6.
Salpeter S, Buckley N, Liu H, Salpeter E
Am J Med
. 2008 Dec;
122(1):42-52.e2.
PMID: 19114171
Purpose: To evaluate the health and economic outcomes of hormone therapy in younger and older postmenopausal women. Methods: We developed a cost-effectiveness model to evaluate outcomes associated with hormone therapy...
7.
Kielstein J, Salpeter S, Buckley N, Cooke J, Fliser D
Kidney Blood Press Res
. 2008 Aug;
31(4):259-67.
PMID: 18689992
Background: Hyperhomocysteinemia is thought to be an independent risk factor for cardiovascular disease, but the association between renal dysfunction and homocysteine may not have been fully taken into account. We...
8.
Salpeter S, Buckley N, Kahn J, Salpeter E
Am J Med
. 2008 Feb;
121(2):149-157.e2.
PMID: 18261504
Purpose: We performed a meta-analysis of randomized controlled trials to assess the effect of metformin on metabolic parameters and the incidence of new-onset diabetes in persons at risk for diabetes....
9.
Salpeter S, Buckley N
Clin Rev Allergy Immunol
. 2006 Nov;
31(2-3):219-30.
PMID: 17085795
Much controversy surrounds the use of beta-agonists in obstructive lung disease. Regular beta2- agonist use in asthma results in tolerance to its effects and an increase in asthma-related deaths. Less...
10.
Salpeter S, Buckley N, Salpeter E
J Gen Intern Med
. 2006 Sep;
21(10):1011-9.
PMID: 16970553
Background: Anticholinergics and beta2-agonists have generally been considered equivalent choices for bronchodilation in chronic obstructive pulmonary disease (COPD). Objective: To assess the safety and efficacy of anticholinergics and beta2-agonists in...